NRXSMICRO

NeurAxis, Inc.

HealthcareBiotechnology
$7.16
$0.00(+1.42%)
52W$2.20
$9.33
Updated Jul 7, 02:00 AM
RSI49
RS Rating87/99
Beta1.27
Volatility75%
F-Score4/9
Mkt Cap$89M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

NeurAxis, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 87), indicating clear outperformance against the broad market. Earnings growth of 45% provides fundamental context to the price action. Investors should exercise caution due to high volatility (75% annualized), which requires wider risk management.

Relative Strength
87
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.27
vs S&P 500
ABOVE MKT
52W Position
70%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$7.42
50 SMA > 100 SMA$6.93
100 SMA > 150 SMA$5.91
150 SMA > 200 SMA$5.16

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$6.95+2.99%ABOVE
50 SMA$7.42-3.45%BELOW
100 SMA$6.93+3.33%ABOVE
150 SMA$5.91+21.07%ABOVE
200 SMA$5.16+38.89%ABOVE

Price Performance

1D+1.4%
1W+0.3%
1M+7.3%
3M-1.2%
6M+60.5%
YTD+60.5%
1Y+165.2%
3Y+6.1%
52-Week Trading Range70% from low
$7.16
52W Low$2.20
52W High$9.33

Technical Indicators

RSI (14)NEUTRAL
49.0
305070
Setup ScoreCOOL
5/10
Base depth: 41.1%

Risk Profile

Beta
1.27
52W Vol
75%
ATR
$0.35
Max DD (1Y)
-40%

Volume Analysis

Today
63.8K
50D Avg
128.3K
Vol Ratio
0.50x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+48%
$-0.22
Q3'25+4%
$-0.24
Q4'25+33%
$-0.16
Q1'26+45%
$-0.18
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+13.08%
3 Years:+9.96%
TTM:+45.88%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+35.48%

Stock Price CAGR

10 Years:+1.78%
5 Years:+3.60%
3 Years:+6.07%
1 Year:+165.19%

Return on Equity

10Y Avg:-933.2%
5Y Avg:-1168.7%
3Y Avg:-1382.9%
Last Year:-185.7%

Key Metrics

Market Cap$89M
Gross Margin84.2%
Net Margin-2.2%
Piotroski F-Score4/9

Frequently Asked Questions

Is NRXS in an uptrend right now?

NRXS has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is NRXS overbought or oversold?

NRXS's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.

Is NRXS outperforming the market?

NRXS has a Relative Strength (RS) Rating of 87 out of 99. Yes, NRXS is a market leader, outperforming 87% of all stocks over the past 12 months.

Where is NRXS in its 52-week range?

NRXS is trading at $7.16, which is 77% of its 52-week high ($9.33) and 70% above its 52-week low ($2.20).

How volatile is NRXS?

NRXS has a Beta of 1.27 and 52-week volatility of 75%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.